Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban in PCI patients - QTc interval safety study
NCT05740371Phase 4Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Apr 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of argatroban, sponsored by Mitsubishi Tanabe Pharma Corporation. Started Apr 2017; status: completed.
02
Drugs
argatroban
Beyond the preview
Go deeper on NCT05740371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05740371.